In addition, the rapid breathing-or hyperventilation-caused by stress can bring on a panic attack in someone prone to panic attacks. Some studies show that an acute stress-such as the death of a loved one-can actually trigger asthma attacks.

For people without respiratory disease, this is generally not a problem as the body can manage the additional work to breathe comfortably, but psychological stressors can exacerbate breathing problems for people with pre-existing respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD includes emphysema and chronic bronchitis). Stress and strong emotions can present with respiratory symptoms, such as shortness of breath and rapid breathing, as the airway between the nose and the lungs constricts. The bronchioles then transfer oxygen to red blood cells for circulation. Air comes in through the nose and goes through the larynx in the throat, down through the trachea, and into the lungs through the bronchi. The respiratory system supplies oxygen to cells and removes carbon dioxide waste from the body. For those who develop chronic pain conditions, stress-relieving activities have been shown to improve mood and daily function. Relaxation techniques and other stress-relieving activities and therapies have been shown to effectively reduce muscle tension, decrease the incidence of certain stress-related disorders, such as headache, and increase a sense of well-being. Muscle tension, and eventually, muscle atrophy due to disuse of the body, all promote chronic, stress-related musculoskeletal conditions. Individuals who are fearful of pain and re-injury, and who seek only a physical cause and cure for the injury, generally have a worse recovery than individuals who maintain a certain level of moderate, physician-supervised activity. What determines whether or not an injured person goes on to suffer from chronic pain is how they respond to the injury. Often, but not always, there may be an injury that sets off the chronic painful state. Millions of individuals suffer from chronic painful conditions secondary to musculoskeletal disorders.

Musculoskeletal pain in the low back and upper extremities has also been linked to stress, especially job stress. When muscles are taut and tense for long periods of time, this may trigger other reactions of the body and even promote stress-related disorders.įor example, both tension-type headache and migraine headache are associated with chronic muscle tension in the area of the shoulders, neck and head. Chronic stress causes the muscles in the body to be in a more or less constant state of guardedness. With sudden onset stress, the muscles tense up all at once, and then release their tension when the stress passes. Muscle tension is almost a reflex reaction to stress-the body’s way of guarding against injury and pain. As the medical industry continues to face unprecedented challenges, it is vital that innovative solutions like these algorithms are developed to ensure that patients receive the best possible care.When the body is stressed, muscles tense up. Kan concludes: “By predicting the blood-brain-barrier permeability of compounds, Lantern Pharma’s AI algorithms can help drug developers to target their efforts more effectively and develop treatments that are more likely to be successful. This breakthrough technology has the potential to revolutionize drug development and improve treatment options for a range of neurological and psychiatric disorders.”Īccording to GlobalData estimates, the total AI market will be worth $383.3 billion in 2030, registering a 21% compound annual growth rate between 20. Kamilla Kan, Medical Analyst at GlobalData, comments: “The development of these algorithms has been influenced by the COVID-19 pandemic, which has highlighted the urgent need for innovative medical solutions. Lantern Pharma’s AI algorithms have the potential to significantly impact the medical industry by improving the efficiency and effectiveness of drug development, says GlobalData, a leading data and analytics company. Lantern Pharma, a clinical-stage biopharmaceutical company, has developed artificial intelligence (AI) algorithms that can predict the blood-brain-barrier permeability of any compound. As the pandemic has continued to impact the world, there has been a growing focus on the importance of developing new treatments for a range of diseases, including those affecting the brain.

Blood brain barrier function